Vanguard Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.9B | Buy |
|
|||||
2025
Q1 | $36.4B | Buy |
|
|||||
2024
Q4 | $30.8B | Buy |
|
|||||
2024
Q3 | $33.9B | Buy |
|
|||||
2024
Q2 | $29.3B | Buy |
|
|||||
2024
Q1 | $31B | Buy |
|
|||||
2023
Q4 | $24.9B | Sell |
|
|||||
2023
Q3 | $24B | Buy |
|
|||||
2023
Q2 | $21.5B | Sell |
|
|||||
2023
Q1 | $25.6B | Buy |
|
|||||
2022
Q4 | $25.6B | Buy |
|
|||||
2022
Q3 | $20.9B | Buy |
|
|||||
2022
Q2 | $23.5B | Buy |
|
|||||
2022
Q1 | $24.4B | Buy |
|
|||||
2021
Q4 | $19.8B | Buy |
|
|||||
2021
Q3 | $15.7B | Buy |
|
|||||
2021
Q2 | $16.3B | Buy |
|
|||||
2021
Q1 | $15.6B | Buy |
|
|||||
2020
Q4 | $15.3B | Sell |
|
|||||
2020
Q3 | $12.6B | Sell |
|
|||||
2020
Q2 | $14.5B | Buy |
|
|||||
2020
Q1 | $9.57B | Buy |
|
|||||
2019
Q4 | $10.9B | Buy |
|
|||||
2019
Q3 | $9.22B | Buy |
|
|||||
2019
Q2 | $8.84B | Buy |
|
|||||
2019
Q1 | $9.74B | Buy |
|
|||||
2018
Q4 | $11.1B | Buy |
|
|||||
2018
Q3 | $11.2B | Buy |
|
|||||
2018
Q2 | $10.9B | Sell |
|
|||||
2018
Q1 | $11.5B | Buy |
|
|||||
2017
Q4 | $11.6B | Buy |
|
|||||
2017
Q3 | $10.5B | Buy |
|
|||||
2017
Q2 | $8.41B | Buy |
|
|||||
2017
Q1 | $7.31B | Buy |
|
|||||
2016
Q4 | $6.86B | Buy |
|
|||||
2016
Q3 | $6.77B | Buy |
|
|||||
2016
Q2 | $6.44B | Buy |
|
|||||
2016
Q1 | $5.89B | Buy |
|
|||||
2015
Q4 | $5.9B | Buy |
|
|||||
2015
Q3 | $5.4B | Sell |
|
|||||
2015
Q2 | $6.79B | Buy |
|
|||||
2015
Q1 | $5.41B | Buy |
|
|||||
2014
Q4 | $5.81B | Buy |
|
|||||
2014
Q3 | $4.96B | Buy |
|
|||||
2014
Q2 | $4.84B | Buy |
|
|||||
2014
Q1 | $4.33B | Buy |
|
|||||
2013
Q4 | $4.35B | Buy |
|
|||||
2013
Q3 | $3.6B | Buy |
|
|||||
2013
Q2 | $3.2B | Buy |
|